{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:39:25Z","timestamp":1787168365845,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2021KY020"],"award-info":[{"award-number":["2021KY020"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001366"],"award-info":[{"award-number":["82001366"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ20H090019"],"award-info":[{"award-number":["LQ20H090019"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jneuroim.2022.577999","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T17:38:37Z","timestamp":1668361117000},"page":"577999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Epileptic seizures in patients with anti-IgLON5 disease"],"prefix":"10.1016","volume":"373","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandar","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577999_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/ane.13207","article-title":"Response to immunotherapy in anti-IgLON5 disease: a systematic review","volume":"141","author":"Cabezudo-Garc\u00eda","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamaneurol.2019.3638","article-title":"Distinctive magnetic resonance imaging findings in IgLON5 antibody disease","volume":"77","author":"Chen","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.800298","article-title":"Epileptic seizures and right-sided hippocampal swelling as presenting symptoms of anti-IgLON5 disease: a case report and systematic review of the literature","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","article-title":"Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease","volume":"32","author":"Gaig","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0025","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577999_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0045","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol. Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0050","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.21037\/qims-21-1213","article-title":"Rare autoimmune encephalitis presenting as fluid-attenuated inversion recovery-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein-associated encephalitis and seizures accompanied with anti-IgLON5 antibody","volume":"12","author":"Li","year":"2022","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0055","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3389\/fimmu.2018.02708","article-title":"Management of autoimmune encephalitis: an observational monocentric study of 38 patients","volume":"9","author":"Macher","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fneur.2018.00329","article-title":"IgLON5-associated encephalitis with atypical brain magnetic resonance imaging and cerebrospinal fluid changes","volume":"9","author":"Montagna","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ene.15117","article-title":"Expanding the clinical spectrum of anti-IgLON5 disease: a multicenter retrospective study","volume":"29","author":"Ni","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bib86","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ene.15117","article-title":"Expanding the clinical spectrum of anti-IgLON5 disease: a multicenter retrospective study","volume":"29","author":"Ni","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236963","article-title":"Musical hallucinations: a rare and atypical presentation of anti-IgLON5 disease responsive to immunosuppressive therapy","volume":"14","author":"Stoyanov","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0080","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/epi.16282","article-title":"Seizure specificities in patients with antibody-mediated autoimmune encephalitis","volume":"60","author":"Vogrig","year":"2019","journal-title":"Epilepsia."},{"key":"10.1016\/j.jneuroim.2022.577999_bb0085","article-title":"Anti-IgLON5 encephalopathy with concomitant herpes virus encephalitis","volume":"1-5","author":"Wang","year":"2022","journal-title":"Neuroimmunomodulation."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:43:15Z","timestamp":1759048995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":18,"alternative-id":["S0165572822001941"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577999","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epileptic seizures in patients with anti-IgLON5 disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577999"}}